CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beauvoir, C.
Right arrow Articles by D'Athis, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beauvoir, C.
Right arrow Articles by D'Athis, F.

Canadian Journal of Anesthesia, Vol 40, 696-702, Copyright © 1993 by Canadian Anesthesiologists' Society

ARTICLES

Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis

C Beauvoir, P Peray, JP Daures, JL Peschaud and F D'Athis
Departement d'Anesthesie-Reanimation A, Hopital Lapeyronie, Montpellier, France.

Eight trials comparing the effects of vecuronium in patients with either normal renal function or renal failure were subjected to a meta-analysis. Vecuronium doses were similar in the different trials, identical in the two patient groups of any given trial, and ranged from 0.05 to 0.14 mg.kg-1. Neuromuscular blockade was assessed by TOF or single twitch stimulation, and recorded by either mechanomyography or electromyography. Indices of blockade included onset time (from injection to maximal twitch depression), duration of action (from injection to recovery to 25% of control twitch) and 25-75% recovery index. Statistical analysis used Hedges method: effect size and variance were calculated for each relevant outcome, then the global effect size was estimated by pooling the effect sizes of each trial. Three separate meta-analyses were conducted. No differences were found either in onset time, or in recovery index between the two groups, whereas the duration of action was longer in the renal failure group. It is concluded that renal function is likely involved in the pharmacokinetic parameters of vecuronium.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
P. F. White, G. Hill, and A. Lenz
Where's the Fire?
Anesth. Analg., September 1, 2007; 105(3): 878 - 878.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. T-L. Choi, S. H. Halpern, N. Malik, A. R. Jadad, M. R. Tramer, and B. Walder
Examining the Evidence in Anesthesia Literature: A Critical Appraisal of Systematic Reviews
Anesth. Analg., March 1, 2001; 92(3): 700 - 709.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Canadian Anesthesiologists' Society.